Catalog |
name |
Description |
price |
R-C-3453 |
DSPE-PEG350-VAP |
As a somatostatin analogue,Vapreotide is used as a modifier of tumor targeting delivery system because of its high affinity with somatostatin receptor.Dspe-peg-vap was prepared by chemical coupling of α-NH2 of D-phenylalanine with nhs-pegdspe, and then modified paclitaxel loaded nano micelle delivery system with dspe-peg-vap. |
price> |
R-C-3454 |
DSPE-polyethylene glycol550-VAP |
As a somatostatin analogue,Vapreotide is used as a modifier of tumor targeting delivery system because of its high affinity with somatostatin receptor.Dspe-peg-vap was prepared by chemical coupling of α-NH2 of D-phenylalanine with nhs-pegdspe, and then modified paclitaxel loaded nano micelle delivery system with dspe-peg-vap. |
price> |
R-C-3455 |
Vapreotide-PEG750-DSPE |
As a somatostatin analogue,Vapreotide is used as a modifier of tumor targeting delivery system because of its high affinity with somatostatin receptor.Dspe-peg-vap was prepared by chemical coupling of α-NH2 of D-phenylalanine with nhs-pegdspe, and then modified paclitaxel loaded nano micelle delivery system with dspe-peg-vap. |
price> |
R-C-3456 |
LyP-1-PEG350-DSPE |
Cyclopeptide LyP-1 modified liposomes:polypeptides as receptor targeted anti-tumor carrier are more and more used to improve the effect of chemotherapy drugs. It has also been proved by experiments that it can enhance the targeting specificity of drugs,enhance the targeted absorption of drugs,improve the anti-tumor effect,and at the same time,it can improve the original insoluble properties of some small molecule drugs.Peptide carrier targeting technology is known as a new generation of targeted drug development technology. |
price> |
R-C-3457 |
LyP-1-polyethylene glycol550-DSPE |
Cyclopeptide LyP-1 modified liposomes:polypeptides as receptor targeted anti-tumor carrier are more and more used to improve the effect of chemotherapy drugs. It has also been proved by experiments that it can enhance the targeting specificity of drugs,enhance the targeted absorption of drugs,improve the anti-tumor effect,and at the same time,it can improve the original insoluble properties of some small molecule drugs.Peptide carrier targeting technology is known as a new generation of targeted drug development technology. |
price> |
R-C-3458 |
DSPE-PEG750-LyP-1 |
Cyclopeptide LyP-1 modified liposomes:polypeptides as receptor targeted anti-tumor carrier are more and more used to improve the effect of chemotherapy drugs. It has also been proved by experiments that it can enhance the targeting specificity of drugs,enhance the targeted absorption of drugs,improve the anti-tumor effect,and at the same time,it can improve the original insoluble properties of some small molecule drugs.Peptide carrier targeting technology is known as a new generation of targeted drug development technology. |
price> |
R-C-3459 |
MC-polyethylene glycol350-DSPE |
After doxorubicin was loaded,MC-DA7R-PEG-DSPE liposomes could effectively inhibit tumor angiogenesis and pseudo angiogenesis,promote apoptosis of glioma cells,and reduce the number of glioma stem cells,thus enhancing the anti glioma effect of doxorubicin.The median survival time of the model animals was longer than that of single targeted molecular modified liposomes (MC-PEG-DSPE liposome and DA7R-PEG-DSPE liposome) 63.6% and 38.5% respectively. |
price> |
R-C-3460 |
DSPE-PEG550-MC |
After doxorubicin was loaded,MC-DA7R-PEG-DSPE liposomes could effectively inhibit tumor angiogenesis and pseudo angiogenesis,promote apoptosis of glioma cells,and reduce the number of glioma stem cells,thus enhancing the anti glioma effect of doxorubicin.The median survival time of the model animals was longer than that of single targeted molecular modified liposomes(MC-PEG-DSPE liposome and DA7R-PEG-DSPE liposome)63.6% and 38.5% respectively. |
price> |
R-C-3461 |
MC-PEG750-DSPE |
After doxorubicin was loaded,MC-DA7R-PEG-DSPE liposomes could effectively inhibit tumor angiogenesis and pseudo angiogenesis,promote apoptosis of glioma cells,and reduce the number of glioma stem cells,thus enhancing the anti glioma effect of doxorubicin.The median survival time of the model animals was longer than that of single targeted molecular modified liposomes (MC-PEG-DSPE liposome and DA7R-PEG-DSPE liposome) 63.6% and 38.5% respectively. |
price> |
R-C-3462 |
MC-DA7R-polyethylene glycol350-DSPE |
MC-DA7R-PEG-DSPE liposome delivery system can transport BBB and BBTB, target glioma cells,stem cells and tumor neovascularization.After doxorubicin was loaded,MC-DA7R-PEG-DSPE liposomes could effectively inhibit tumor angiogenesis and pseudo angiogenesis,promote apoptosis of glioma cells,and reduce the number of glioma stem cells,thus enhancing the anti glioma effect of doxorubicin.The median survival time of the model animals was longer than that of single targeted molecular modified liposomes (MC-PEG-DSPE liposome and DA7R-PEG-DSPE liposome) 63.6% and 38.5% respectively. |
price> |